Phase III study of BCL-family inhibitors in lymphoma
$0Z01FY2006BCNIH
Basic Sciences
Investigators
Abstract
Determine safety and activity of new class of bcl-family inhibitors
View original record on NIH RePORTER →Basic Sciences
Determine safety and activity of new class of bcl-family inhibitors
View original record on NIH RePORTER →